mGlu1 Receptor Illustration (1 of 3) (IMAGE) Scripps Research Institute Caption Researchers at the Scripps Research Institute and Vanderbilt University have achieved an important new understanding of the mGlu1 receptor, a target for future medicines for the treatment of brain disorders. Credit Image by Katya Kadyshevskaya, courtesy of the Scripps Research Institute Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.